Raleigh Capital Management Inc. Dexcom Inc Transaction History
Raleigh Capital Management Inc.
- $255 Million
- Q3 2024
A detailed history of Raleigh Capital Management Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 119 shares of DXCM stock, worth $9,449. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119
Previous 152
21.71%
Holding current value
$9,449
Previous $17,000
58.82%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding DXCM
# of Institutions
1,015Shares Held
352MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.77 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.74 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.43 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.32 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.19 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $30.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...